Phase IIa dose-escalation study of insulin glargine/insulin lispro (BioChaperone Combo)
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2016
At a glance
- Drugs Insulin glargine/insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Adocia
- 14 Apr 2016 According to an Adocia media release, this study is scheduled to start in the second quarter of 2016.
- 20 Jan 2015 According to an Adocia media release, this study is scheduled for first quarter of 2015.
- 05 Nov 2014 New trial record